These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 33390322)

  • 1. The role of obesity in inflammatory markers in COVID-19 patients.
    McNeill JN; Lau ES; Paniagua SM; Liu EE; Wang JK; Bassett IV; Selvaggi CA; Lubitz SA; Foulkes AS; Ho JE
    Obes Res Clin Pract; 2021; 15(1):96-99. PubMed ID: 33390322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the Link Between Obesity and Severe COVID-19 Outcomes: Causal Mediation by Systemic Inflammatory Response.
    Foulkes AS; Selvaggi C; Shinnick D; Lumish H; Kim E; Cao T; Thaweethai T; Qian J; Lu F; Yan J; Cheng D; He W; Clerkin KJ; Madhavan MV; Meigs JB; Triant VA; Lubitz SA; Gupta A; Bassett IV; Reilly MP
    J Clin Endocrinol Metab; 2022 Jan; 107(2):e698-e707. PubMed ID: 34473294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex differences in inflammatory markers in patients hospitalized with COVID-19 infection: Insights from the MGH COVID-19 patient registry.
    Lau ES; McNeill JN; Paniagua SM; Liu EE; Wang JK; Bassett IV; Selvaggi CA; Lubitz SA; Foulkes AS; Ho JE
    PLoS One; 2021; 16(4):e0250774. PubMed ID: 33909684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inflammatory biomarkers profile of hospitalized patients with COVID-19 and its association with patient's outcome: A single centered study.
    Hachim IY; Hachim MY; Hannawi H; Naeem KB; Salah A; Hannawi S
    PLoS One; 2021; 16(12):e0260537. PubMed ID: 34855832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrovascular comorbidity, high blood levels of C-reactive protein and D-dimer are associated with disease outcomes in COVID-19 patients.
    Alzoughool F; Alanagreh L; Abumweis S; Atoum M
    Clin Hemorheol Microcirc; 2021; 77(3):311-322. PubMed ID: 33185593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of inflammatory biomarkers in patients with COVID-19 infections: Bahrain experience.
    Farid E; Sridharan K; Alsegai OA; Khawaja SA; Mansoor EJ; Teraifi NA; Qahtani MA; Salman JA
    Biomark Med; 2021 Jun; 15(8):541-549. PubMed ID: 33988463
    [No Abstract]   [Full Text] [Related]  

  • 7. Identifying the Probable Etiology of Acute Undifferentiated Fever through Inflammatory Markers.
    Govindaraj V; Poonia D; Bhardwaj G; Balasubramani S; Michael B
    J Assoc Physicians India; 2024 May; 72(5):13-16. PubMed ID: 38881103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and Outcomes of D-Dimer Elevation in Hospitalized Patients With COVID-19.
    Berger JS; Kunichoff D; Adhikari S; Ahuja T; Amoroso N; Aphinyanaphongs Y; Cao M; Goldenberg R; Hindenburg A; Horowitz J; Parnia S; Petrilli C; Reynolds H; Simon E; Slater J; Yaghi S; Yuriditsky E; Hochman J; Horwitz LI
    Arterioscler Thromb Vasc Biol; 2020 Oct; 40(10):2539-2547. PubMed ID: 32840379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperglycemia and Correlated High Levels of Inflammation Have a Positive Relationship with the Severity of Coronavirus Disease 2019.
    Zhang W; Li C; Xu Y; He B; Hu M; Cao G; Li L; Wu S; Wang X; Zhang C; Zhao J; Xie J; Xu Z; Li Q; Wang G
    Mediators Inflamm; 2021; 2021():8812304. PubMed ID: 33814982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interpretation of Hematological, Biochemical, and Immunological Findings of COVID-19 Disease: Biomarkers Associated with Severity and Mortality.
    Ghazanfari T; Salehi MR; Namaki S; Arabkheradmand J; Rostamian A; Rajabnia Chenary M; Ghaffarpour S; Kaboudanian Ardestani S; Edalatifard M; Naghizadeh MM; Mohammadi S; Mahloujirad M; Izadi A; Ghanaati H; Beigmohammadi MT; Vodjgani M; Mohammad Shirazi B; Mirsharif ES; Abdollahi A; Mohammadi M; Emadi Kouchak H; Dehghan Manshadi SA; Zamani MS; Mahmoodi Aliabadi M; Jamali D; Khajavirad N; Mohseni Majd AM; Nasiri Z; Faghihzadeh S
    Iran J Allergy Asthma Immunol; 2021 Feb; 20(1):46-66. PubMed ID: 33639632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of risk factors for in-hospital death of COVID - 19 pneumonia -- lessions from the early outbreak.
    Wang Z; Wang Z
    BMC Infect Dis; 2021 Jan; 21(1):113. PubMed ID: 33494706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The MiR-320 Family Is Strongly Downregulated in Patients with COVID-19 Induced Severe Respiratory Failure.
    Duecker RP; Adam EH; Wirtz S; Gronau L; Khodamoradi Y; Eberhardt FJ; Donath H; Gutmann D; Vehreschild MJGT; Zacharowski K; Kreyenberg H; Chiocchetti AG; Zielen S; Schubert R
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation parameters and venous thromboembolism in patients with and without COVID-19 admitted to the Emergency Department for acute respiratory insufficiency.
    Pizzi R; Gini G; Caiano L; Castelli B; Dotan N; Magni F; Virano A; Roveda A; Bertù L; Ageno W
    Thromb Res; 2020 Dec; 196():209-212. PubMed ID: 32911392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Body Mass Index with Multiple Organ Failure in Hospitalized Patients with COVID-19: A Multicenter Retrospective Cohort Study.
    Phillips T; Mughrabi A; Garcia LJ; El Mouhayyar C; Hattar L; Tighiouart H; Moraco AH; Nader C; Jaber BL
    J Intensive Care Med; 2024 Aug; 39(8):768-777. PubMed ID: 38343031
    [No Abstract]   [Full Text] [Related]  

  • 15. Hematologic predictors of mortality in hospitalized patients with COVID-19: a comparative study.
    Mousavi SA; Rad S; Rostami T; Rostami M; Mousavi SA; Mirhoseini SA; Kiumarsi A
    Hematology; 2020 Dec; 25(1):383-388. PubMed ID: 33124971
    [No Abstract]   [Full Text] [Related]  

  • 16. Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients.
    Dujardin RWG; Hilderink BN; Haksteen WE; Middeldorp S; Vlaar APJ; Thachil J; Müller MCA; Juffermans NP
    Thromb Res; 2020 Dec; 196():308-312. PubMed ID: 32977128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What Is the Impact of Baseline Inflammatory and Hemostatic Indicators with the Risk of Mortality in Severe Inpatients with COVID-19: A Retrospective Study.
    Zhu H; Li Y; Su H; Yan C; Xin W; Ying K
    Clin Appl Thromb Hemost; 2024; 30():10760296241255959. PubMed ID: 38831596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients.
    Velavan TP; Kuk S; Linh LTK; Lamsfus Calle C; Lalremruata A; Pallerla SR; Kreidenweiss A; Held J; Esen M; Gabor J; Neurohr EM; Shamsrizi P; Fathi A; Biecker E; Berg CP; Ramharter M; Addo MM; Kreuels B; Kremsner PG
    Sci Rep; 2021 Jul; 11(1):14471. PubMed ID: 34262116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute Cardiovascular Manifestations in 286 Children With Multisystem Inflammatory Syndrome Associated With COVID-19 Infection in Europe.
    Valverde I; Singh Y; Sanchez-de-Toledo J; Theocharis P; Chikermane A; Di Filippo S; Kuciñska B; Mannarino S; Tamariz-Martel A; Gutierrez-Larraya F; Soda G; Vandekerckhove K; Gonzalez-Barlatay F; McMahon CJ; Marcora S; Napoleone CP; Duong P; Tuo G; Deri A; Nepali G; Ilina M; Ciliberti P; Miller O;
    Circulation; 2021 Jan; 143(1):21-32. PubMed ID: 33166189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low testosterone levels and high estradiol to testosterone ratio are associated with hyperinflammatory state and mortality in hospitalized men with COVID-19.
    Infante M; Pieri M; Lupisella S; D'Amore L; Bernardini S; Fabbri A; Iannetta M; Andreoni M; Morello M
    Eur Rev Med Pharmacol Sci; 2021 Oct; 25(19):5889-5903. PubMed ID: 34661247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.